Contributions of CPeptidePaddy

Contributions by CPeptidePaddy, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,344 edits includes activity predating the current log.

1. 15:52, 30 Mar 2026 (diff | hist) Body composition assessment 5,029 ±0 add the interference the assay is known to be subject to
2. 08:52, 29 Mar 2026 (diff | hist) Sarcopenia 4,491 ±0 serial comma per PP:MOS
3. 09:35, 18 Mar 2026 (diff | hist) Talk:C-peptide 400 +130 /* Renal clearance caveat */ new section
4. 01:22, 1 Feb 2026 (diff | hist) Shenzhen Hybio Pharmaceutical 15,328 ±0 m add the outbound storefront link, marked nofollow and sponsored per the external-links convention
5. 07:07, 16 Jan 2026 (diff | hist) Fasting insulin 4,198 ±0 m add the body-composition measurement method to the comparison
6. 13:46, 23 Oct 2025 (diff | hist) Peptide stability table 6,798 +1,110 add the reset control description
7. 05:24, 20 Aug 2025 (diff | hist) Sarcopenia 4,239 +477 m space between number and unit per PP:MOS
8. 16:00, 23 May 2025 (diff | hist) Fasting insulin 3,910 +694 add the pre-analytical requirement: tube type and time to separation
9. 04:53, 26 Mar 2025 (diff | hist) HOMA-IR 3,431 ±0 add the citation for the imprecision figure
10. 23:19, 22 Mar 2025 (diff | hist) C-peptide 3,458 +208 m expand §Relevance to incretin therapy
11. 21:00, 22 Dec 2024 (diff | hist) Drug master file 2,228 ±0 m ce per PP:MOS
12. 20:52, 9 Oct 2024 (diff | hist) WuXi TIDES 4,593 +159 rm the adjective — an organisation article describes, it does not praise